Company Filing History:
Years Active: 1989-1990
Title: Innovations of Stanley S. Greenberg
Introduction
Stanley S. Greenberg is a notable inventor based in Morris Plains, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cardiovascular agents. With a total of two patents to his name, Greenberg's work has had a meaningful impact on medical science.
Latest Patents
Greenberg's latest patents include the development of novel N-[4-(aminosubstituted)phenyl]methanesulfonamides. These compounds are described for their use as cardiovascular agents, especially as antiarrhythmic agents. The patents also discuss pharmaceutical formulations containing such compounds. Additionally, he has worked on novel 1-(4-substituted phenyl)-1H-imidazoles, which are described for their use as antiarrhythmic, anti-hypertensive, and anti-ischemic agents. These formulations also include pharmaceutical applications.
Career Highlights
Stanley S. Greenberg is associated with Schering Aktiengesellschaft, a company known for its focus on innovative pharmaceutical solutions. His work has contributed to advancements in cardiovascular treatments, showcasing his expertise in the field.
Collaborations
Some of his notable coworkers include William C. Lumma, Jr. and Klaus Nickisch. Their collaborative efforts have further enhanced the research and development of effective pharmaceutical agents.
Conclusion
Stanley S. Greenberg's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cardiovascular medicine.